Agency Information Collection Activities; Submission for OMB Review; Comment Request; Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices

Краткое содержание

The Food and Drug Administration (FDA) is announcing that the proposed collection of information entitled "Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.